Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer

Table 1

Clinical material of patient and control groups.

Clinical features	Patient group	Control group	Percentage (% of total)
Gender
Male	41	14	69.49/58.33
Female	18	10	30.51/41.67
Age
<60	32	14	54.37/58.33
≥60	27	10	45.63/41.67
T stage
T1	0		0.00
T2	14		23.73
T3	21		35.59
T4	24		40.68
N stage
N0	6		10.17
N1	11		18.64
N2	42		71.19
M stage
M0	48		81.36
M1	11		18.64
TNM stage
I	2		3.39
II	4		6.78
III	42		71.19
IV	11		18.64
Differentiation
Low	7		11.86
Middle	47		79.66
High	5		8.48
Histology
Squamous	2		3.39
Mucoid	57		96.61

Note: T means the depth of tumor cell infiltration; N means the level of lymph node metastasis; M means the condition of metastasis.